Adjuvant therapy for rectal cancer.
Clin Colon Rectal Surg., Aug;20(3):167-81 (2007)
Evaluation and management of incidental thyroid nodules in patients with another primary malignancy.
Surgery., Oct;142(4):581-6; discussion 586-7 (2007)
A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma.
Cancer Chemother. Pharmacol., Apr;63(5):851-7 (2009)
Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.
Cancer Chemother. Pharmacol., Aug (2012)
Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.
Cancer Chemother. Pharmacol., Feb;63(3):441-50 (2009)
Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study.
Ann. Oncol., Jul;17(7):1096-102 (2006)